摘要
微创靶向消融治疗为肺癌患者提供了一种新的治疗手段。其适应证广泛,局部控制率和生存期评价良好,并发症发生率低且可控,有效性和安全性都已得到临床验证。
The development of the minimally invasive targeted ablation tendency creates a new therapy for lung cancer. This treatment is featured with considerably extensive indication, excellent local control and survival time, low incidence and controllable complications. There are many strong proofs of clinical efficacy and safety in this field presently.
出处
《国际肿瘤学杂志》
CAS
2011年第4期282-285,共4页
Journal of International Oncology
关键词
肺肿瘤
射频
微波
Lung neoplasms
Radiofrequency
Microwaves